Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - NEUROCRINE BIOSCIENCES INC | Financial_Report.xls |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - NEUROCRINE BIOSCIENCES INC | d263842dex312.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - NEUROCRINE BIOSCIENCES INC | d263842dex311.htm |
| EX-21.1 - SUBSIDIARIES OF THE COMPANY - NEUROCRINE BIOSCIENCES INC | d263842dex211.htm |
| 10-K - FORM 10-K - NEUROCRINE BIOSCIENCES INC | d263842d10k.htm |
| EX-32 - CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - NEUROCRINE BIOSCIENCES INC | d263842dex32.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-31791, 333-57875, 333-87127, 333-44012, 333-57096, 333-65198, 333-92328, 333-101756, 333-105907, 333-118773, 333-127214, 333-135909, 333-147120, 333-152689, 333-160934, and 333-175889) and Form S-3 (Nos. 333-162741 and 333-171022) of Neurocrine Biosciences, Inc. of our reports dated February 9, 2012, with respect to the consolidated financial statements of Neurocrine Biosciences, Inc., and the effectiveness of internal control over financial reporting of Neurocrine Biosciences, Inc., included in this Annual Report (Form 10-K) of Neurocrine Biosciences, Inc. for the year ended December 31, 2011.
/s/ Ernst & Young LLP
San Diego, California
February 9, 2012